Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Post by valentinemassonon Aug 08, 2020 2:43am
350 Views
Post# 31382165

Seems as though some have not yet applied,

Seems as though some have not yet applied,
 We are doing Beckman-Coulter tests , that is approved as per the following list , in no way pumping or deterring from other companies, but  as a cautionary note Sona does not appear on this list as having applied for EUA or in any regard. MIR shows on the list as pending submisson. Having experienced  the rise and fall of pot stocks in 2018/2019 , hype can be a great money maker but as we all know can be quite dangerous. Have bought and sold both Sona and Mir, albeit long before the rise in Sona.

  Many that come here seem to question the history of SZLS - although some of you have held this for far longer than I , the potential here seems quite realistic - here`s hoping that Q2 sheds some light on Q3 revenues , with our new partnerships in the field and James mentioning Aristotle launched by EOY and quite firm in saying that the past is past and mentioning the "B" word ,(billion dollar market) performing CLIA certification tests garnering attention to detail and precision coupled with several job postings can only mean that unlike other hype companies , this is the real deal. The radio silence at times is deafening , but as another poster mentioned earlier , short interests have dropped here considerably as per shortdata.ca - we know the market is saying,"enough talk, show me the money" . Without a doubt, revenue is being generated through our CLIA lab , to what extent will be seen with an idea as to what we may see in Q3 before Aristotle launches , probably in the US market. Even though Stage is a Canadian company, they are on American soil and historically American interests on home soil have fared well when performing in that economy.

 Enough rambling, glta , here is the link for submissions to FDA . Good Knight everyone.

 VM.

 FDA Submissions

 
Bullboard Posts